...
机译:中间体或晚期肝细胞癌患者肿瘤释放术难以进行化疗栓塞的安全性和疗效
Department of Radiology University Hospitals Leuven;
Department of Radiology University Hospitals Leuven;
Department of Digestive Oncology University Hospitals Leuven;
Department of Biostatistics and Statistical Bioinformatics KU Leuven Universiteit Hasselt;
Department of Pathology University Hospitals Leuven;
Nuclear Medicine University Hospitals Leuven;
Department of Radiology University Hospitals Leuven;
Department of Radiology University Hospitals Leuven;
Department of Radiology University Hospitals Leuven;
HCC; Chemoembolisation; Radioembolisation; Yttrium-90; Microspheres; Survival; Adverse events; Selective internal radiation therapy;
机译:中间体或晚期肝细胞癌难治性致脉细胞抑制患者的rantarterial放射栓塞的安全性和有效性
机译:立体定向放疗联合经动脉化学栓塞治疗中国中晚期肝细胞癌的疗效和安全性:系统评价和荟萃分析
机译:立体定向体放射治疗的疗效和安全性联合中国中间至晚期肝细胞癌患者的龙动化疗栓塞:系统审查与荟萃分析
机译:改进的肝细胞癌对经动脉化疗栓塞反应的定量对比增强超声成像
机译:倍半萜类药物可作为肝细胞癌(HCC)的潜在治疗方法:在大鼠HCC肿瘤模型中,通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
机译:阿帕替尼在经导管动脉化疗栓塞(TACE)难治性中晚期肝细胞癌中的疗效:倾向评分匹配分析
机译:立体定向体放射治疗的疗效和安全性联合中国中间至晚期肝细胞癌患者的龙动化疗栓塞:系统审查与荟萃分析